Cystic Fibrosis (CF) is an autosomal recessive disease, caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. Approximately 1,400 people are living with CF in Ireland. Due to improved management, including availability of CFTR modulators, median predicted survival age has risen from 38.2 years in 2009 to 51.8 years in 2021.
The aim of this course is to provide an update on the management of CF, including the use of High Tech medicines.
Epilepsy is a complex neurological disorder in which a person has recurrent epileptic seizures. It affects approximately 45,000 people in Ireland. Epilepsy can occur at any stage of life but diagnosis peaks in early childhood and later in life. Conditions such as dementia or stroke are associated with an increased incidence of epilepsy.
The aim of this course is to provide an overview of the management of epilepsy and address some of the challenges faced by certain patient groups.
Venous leg ulcers are chronic sores, usually just above the ankle, that take more than two weeks to heal [HSE]. They are the most common type of leg ulcer and affect approximately 1 in 500 people in Ireland. Venous leg ulcers become more common with increasing age and are a significant cause of pain and reduced mobility.
The aim of this course is to provide an update on the causes and complicating factors of venous leg ulcers, to enable pharmacists to support patients in the management of this condition.
Stroke is the second leading cause of death in middle-to-higher income countries and the leading cause of acquired neurological disability in Ireland [HSE].
This aim of this course is to provide pharmacists with an overview of the recommended pharmacological and non-pharmacological strategies for the prevention and management of stroke and transient ischaemic attacks (TIAs).